Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease
- PMID: 3014387
- DOI: 10.1016/0304-3940(86)90190-4
Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease
Abstract
Brains of normal controls and patients with primary degenerative dementia were investigated for choline acetyltransferase (ChAT) activity in the frontal, temporal and parietal cortex, hippocampus, amygdala and thalamus. A few patients with Alzheimer's disease were unusual as the cholinergic marker was unaffected, except in the amygdala. Other patients with dementia and undiagnosed neurodegenerative disorder had elevated cortical ChAT activity. The interpretations offered are: (a) the syndrome of dementia and Alzheimer pathologic change precedes significant loss of cortical cholinergic innervation; (b) denervation in dementia can occur early in olfactory areas, exemplified here by the amygdala; (c) dementia is associated with the loss of non-cholinergic structure. An indication of structures involved was given by loss of a marker of excitatory amino acid-releasing neurones.
Similar articles
-
Selective loss of central cholinergic neurons in Alzheimer's disease.Lancet. 1976 Dec 25;2(8000):1403. doi: 10.1016/s0140-6736(76)91936-x. Lancet. 1976. PMID: 63862 No abstract available.
-
Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls.Neurosci Lett. 1983 Apr 11;36(2):195-9. doi: 10.1016/0304-3940(83)90264-1. Neurosci Lett. 1983. PMID: 6866327
-
Degeneration of the cholinergic innervation of the locus ceruleus in Alzheimer's disease.Brain Res. 1991 Feb 22;542(1):23-8. doi: 10.1016/0006-8993(91)90992-5. Brain Res. 1991. PMID: 2054656
-
Cholinergic markers in the cortex and hippocampus of some animal species and their correlation to Alzheimer's disease.Neurologia. 2014 Oct;29(8):497-503. doi: 10.1016/j.nrl.2012.10.007. Epub 2013 Feb 22. Neurologia. 2014. PMID: 23433740 Review. English, Spanish.
-
Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?FASEB J. 1990 Jul;4(10):2745-52. doi: 10.1096/fasebj.4.10.2165009. FASEB J. 1990. PMID: 2165009 Review.
Cited by
-
A quantitative study of the neurofibrillary tangles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer's disease.J Neurol Neurosurg Psychiatry. 1990 Feb;53(2):161-5. doi: 10.1136/jnnp.53.2.161. J Neurol Neurosurg Psychiatry. 1990. PMID: 2313304 Free PMC article.
-
Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain.Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10955-9. doi: 10.1073/pnas.89.22.10955. Proc Natl Acad Sci U S A. 1992. PMID: 1279699 Free PMC article.
-
Hippocampal plasticity during the progression of Alzheimer's disease.Neuroscience. 2015 Nov 19;309:51-67. doi: 10.1016/j.neuroscience.2015.03.006. Epub 2015 Mar 12. Neuroscience. 2015. PMID: 25772787 Free PMC article. Review.
-
The cholinergic hypothesis of Alzheimer's disease: a review of progress.J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):137-47. doi: 10.1136/jnnp.66.2.137. J Neurol Neurosurg Psychiatry. 1999. PMID: 10071091 Free PMC article. Review.
-
Multifaceted Alzheimer's Disease: Building a Roadmap for Advancement of Novel Therapies.Neurochem Res. 2021 Nov;46(11):2832-2851. doi: 10.1007/s11064-021-03415-w. Epub 2021 Aug 6. Neurochem Res. 2021. PMID: 34357520 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical